Adapting the plant defense systems’ toolbox of Michael acceptors to electrophilic drug development

Abstract

Plant metabolites are an invaluable source of bioactive molecules, and a high percentage of them can react covalently with their targets. Lipid-derived α,β-unsaturated systems (Michael acceptors), which are present in all plants, regulate signaling pathways in cells. In addition, they potentially represent novel molecular targets and mechanisms of action in drug development. The irreversible covalent binding of the majority of these electrophilic molecules to their corresponding molecular targets, combined with, in certain cases, unfavorable pharmacokinetic properties, i.e., absorption, distribution, metabolism, and excretion (ADME), has shifted their use predominantly to that of molecular probes for target identification. In this review, we present examples of structural modification of the original naturally occurring Michael acceptor-containing compounds, as well as examples of incorporating naturally occurring functionalities in the design of reversible covalent probes and drug candidates in order to improve ADME and increase target selectivity.

Keywords

Michael acceptors / plants’ defense mechanisms / cycloenones / prodrugs

References

[1] Gehrtz P, London N. Electrophilic Natural Products as Drug Discovery Tools. Trends Pharmacol Sci. 2021; 42: 434-47.

[2] Nomura DK, Maimone TJ. Target Identification of Bioactive Covalently Acting Natural Products. Curr Top Microbiol Immunol. 2019; 420: 351-74.

[3] Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997; 236: 313—22.

[4] Miao W, Hu L, Scrivens PJ, Batist G. Transcriptional regulation of NF—E2 p45—related factor (NRF2) expression by the aryl hydrocarbon receptor—xenobiotic response element signaling pathway: direct cross—talk between phase I and II drug—metabolizing enzymes. J Biol Chem. 2005; 280: 20340—8.

[5] Kobayashi A, Kang MI, Okawa H, Ohtsuji M, Zenke Y, Chiba T, et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3—based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol. 2004; 24: 7130-9.

[6] Cullinan SB, Gordan JD, Jin J, Harper JW, Diehl JA. The Keap1—BTB protein is an adaptor that bridges Nrf2 to a Cul3—based E3 ligase: oxidative stress sensing by a Cul3—Keap1 ligase. Mol Cell Biol. 2004; 24: 8477-86.

[7] Zhang DD, Lo SC, Cross JV, Templeton DJ, Hannink M. Keap1 is a redox—regulated substrate adaptor protein for a Cul3—dependent ubiquitin ligase complex. Mol Cell Biol. 2004; 24: 10941-53.

[8] Dinkova—Kostova AT, Holtzclaw WD, Kensler TW. The role of Keap1 in cellular protective responses. Chem Res Toxicol. 2005; 18: 1779-91.

[9] Roviello GN. Nature—Inspired Pathogen and Cancer Protein Covalent Inhibitors: From Plants and Other Natural Sources to Drug Development. Pathogens. 2025; 14: 1153.

[10] Sun DJ, Zhu LJ, Zhao YQ, Zhen YQ, Zhang L, Lin CC, et al. Diarylheptanoid: A privileged structure in drug discovery. Fitoterapia. 2020; 142: 104490.

[11] Liang ST, Chen C, Chen RX, Li R, Chen WL, Jiang GH, et al. Michael acceptor molecules in natural products and their mechanism of action. Front Pharmacol. 2022; 13: 1033003.

[12] Johnson J, Olson MB, Parker I, Hoffmeister I, Lemkau K. Widespread Production of Polyunsaturated Aldehydes by Benthic Diatoms of the North Pacific Ocean’s Salish Sea. J Chem Ecol. 2024; 50: 290-8.

[13] Liang X, Qian R, Wang D, Liu L, Sun C, Lin X. Lipid—Derived Aldehydes: New Key Mediators of Plant Growth and Stress Responses. Biology (Basel). 2022; 11: 1590.

[14] Goulitquer S, Ritter A, Thomas F, Ferec C, Salaün JP, Potin P. Release of volatile aldehydes by the brown algal kelp Laminaria digitata in response to both biotic and abiotic stress. Chembiochem. 2009; 10: 977-82.

[15] Engelberth J. Primed to grow: a new role for green leaf volatiles in plant stress responses. Plant Signal Behav. 2020; 15: 1701240.

[16] Mirabella R, Rauwerda H, Struys EA, Jakobs C, Triantaphylidès C, Haring MA, et al. The Arabidopsis her1 mutant implicates GABA in E—2—hexenal responsiveness. Plant J. 2007; 53: 197-213.

[17] Mano J, Biswas MS, Sugimoto K. Reactive Carbonyl Species: A Missing Link in ROS Signaling. Plants. 2019; 8: 391.

[18] Caboni P, Ntalli NG, Aissani N, Cavoski I, Angioni A. Nematicidal Activity of (E,E)—2,4—Decadienal and (E)—2—Decenal from Ailanthus altissima against Meloidogyne javanica. J Agric Food Chem. 2012; 60: 1146-51.

[19] Liang X, Ou Y, Zhao H, Zhou W, Sun C, Lin X. Lipid Peroxide—Derived Short—Chain Aldehydes are Involved in Aluminum Toxicity of Wheat (Triticum aestivum) Roots. J Agric Food Chem. 2021; 69: 10496-505.

[20] Biswas MS, Mano J. Lipid Peroxide—Derived Reactive Carbonyl Species as Mediators of Oxidative Stress and Signaling. Front Plant Sci. 2021; 12: 720867.

[21] Winger AM, Millar AH, Day DA. Sensitivity of plant mitochondrial terminal oxidases to the lipid peroxidation product 4—hydroxy—2—nonenal (HNE). Biochem J. 2005; 387: 865-70.

[22] Schneider C, Boeglin WE, Yin H, Ste DF, Hachey DL, Porter NA, et al. Synthesis of dihydroperoxides of linoleic and linolenic acids and studies on their transformation to 4—hydroperoxynonenal. Lipids. 2005; 40: 1155-62.

[23] Pohnert G. Wound—Activated Chemical Defense in Unicellular Planktonic Algae. Angew Chem Int Ed Engl. 2000; 39: 4352-4.

[24] Ianora A, Miralto A, Poulet SA, Carotenuto Y, Buttino I, Romano G, et al. Aldehyde suppression of copepod recruitment in blooms of a ubiquitous planktonic diatom. Nature. 2004; 429: 403-7.

[25] Ianora A, Bastianini M, Carotenuto Y, Casotti R, Roncalli V, Miralto A, et al. Non—volatile oxylipins can render some diatom blooms more toxic for copepod reproduction. Harmful Algae. 2015; 44: 1-7.

[26] Schwartz ER, Poulin RX, Mojib N, Kubanek J. Chemical ecology of marine plankton. Nat Prod Rep. 2016; 33: 843-60.

[27] Brown ER, Cepeda MR, Mascuch SJ, Poulson—Ellestad KL, Kubanek J. Chemical ecology of the marine plankton. Nat Prod Rep. 2019; 36: 1093-116.

[28] Li S, Hu M, Tong Y, Xia Z, Tong Y, Sun Y, et al. A review of volatile compounds in edible macroalgae. Food Res Int. 2023; 165: 112559.

[29] Wolfe GV, Steinke M, Kirst GO. Grazing—activated chemical defence in a unicellular marine alga. Nature. 1997; 387: 894-7.

[30] Boonprab K, Matsui K, Yoshida M, Akakabe Y, Chirapart A, Kajiwara T. C6—Aldehyde Formation by Fatty Acid Hydroperoxide Lyase in the Brown Alga Laminaria angustata. Z Naturforsch C J Biosci. 2014; 58: 207—14.

[31] Xing Q, Cabioch L, Desrut A, Le Corguillé G, Rousvoal S, Dartevelle L, et al. Aldehyde perception induces specific molecular responses in Laminaria digitata and affects algal consumption by a specialist grazer. Plant J. 2023; 116: 1617—32.

[32] Amélie S, Salomé C, Xuan—Minh—Ai N, Abdessalem S, Elena O, Catherine F. Biogenic volatile organic compounds from marine benthic organisms: a review. Mar Environ Res. 2025; 209: 107162.

[33] Winger AM, Taylor NL, Heazlewood JL, Day DA, Millar AH. The Cytotoxic lipid peroxidation product 4—hydroxy—2—nonenal covalently modifies a selective range of proteins linked to respiratory function in plant mitochondria. J Biol Chem. 2007; 282: 37436-47.

[34] Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4—hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991; 11: 81-128.

[35] Dalleau S, Baradat M, Guéraud F, Huc L. Cell death and diseases related to oxidative stress: 4—hydroxynonenal (HNE) in the balance. Cell Death Differ. 2013; 20: 1615-30.

[36] Milkovic L, Zarkovic N, Marusic Z, Zarkovic K, Jaganjac M. The 4—Hydroxynonenal—Protein Adducts and Their Biological Relevance: Are Some Proteins Preferred Targets? Antioxidants. 2023; 12: 856.

[37] Zhai X, Zhang Z, Liu W, Liu B, Zhang R, Wang W, et al. Protective effect of ALDH2 against cyclophosphamide—induced acute hepatotoxicity via attenuating oxidative stress and reactive aldehydes. Biochem Biophys Res Commun. 2018; 499: 93-8.

[38] Di Domenico F, Tramutola A, Butterfield DA. Role of 4—hydroxy—2—nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age—related neurodegenerative disorders. Free Radic Biol Med. 2017; 111: 253-61.

[39] Sottero B, Leonarduzzi G, Testa G, Gargiulo S, Poli G, Biasi F. Lipid Oxidation Derived Aldehydes and Oxysterols Between Health and Disease. Eur J Lipid Sci Technol. 2018; 121: e121.

[40] Stone MP, Cho YJ, Huang H, Kim HY, Kozekov ID, Kozekova A, et al. Interstrand DNA Cross—Links Induced by α,β—Unsaturated Aldehydes Derived from Lipid Peroxidation and Environmental Sources. Acc Chem Res. 2008; 41: 793-804.

[41] Vijayraghavan S, Saini N. Aldehyde—Associated Mutagenesis─Current State of Knowledge. Chem Res Toxicol. 2023; 36: 983-1001.

[42] Mc Gee D, Archer L, Parkes R, Fleming GTA, Santos HM, Touzet N. The role of methyl jasmonate in enhancing biomass yields and bioactive metabolites in Stauroneis sp. (Bacillariophyceae) revealed by proteome and biochemical profiling. J Proteom. 2021; 249: 104381.

[43] Liu H, Chen Y, Wang H, Huang Y, Hu Y, Zhao Y, et al. Identification of Potential Factors for the Promotion of Fucoxanthin Synthesis by Methyl Jasmonic Acid Treatment of Phaeodactylum tricornutum. Mar Drugs. 2023; 22: 7.

[44] Bassi R, Dall’Osto L. Dissipation of Light Energy Absorbed in Excess: The Molecular Mechanisms. Annu Rev Plant Biol. 2021; 72: 47-76.

[45] Bai Y, Cao T, Dautermann O, Buschbeck P, Cantrell MB, Chen Y, et al. Green diatom mutants reveal an intricate biosynthetic pathway of fucoxanthin. Proc Natl Acad Sci. 2022; 119: e2203708119.

[46] de Freitas Silva M, Pruccoli L, Morroni F, Sita G, Seghetti F, Viegas C, et al. The Keap1/Nrf2—ARE Pathway as a Pharmacological Target for Chalcones. Molecules. 2018; 23: 1803.

[47] Mohibbullah M, Haque MN, Sohag AAM, Hossain MT, Zahan MS, Uddin MJ, et al. A Systematic Review on Marine Algae—Derived Fucoxanthin: An Update of Pharmacological Insights. Mar Drugs. 2022; 20: 279.

[48] Andrés CMC, Pérez de la Lastra JM, Bustamante Munguira E, Andrés Juan C, Pérez—Lebeña E. Michael Acceptors as Anti—Cancer Compounds: Coincidence or Causality? Int J Mol Sci. 2024; 25: 6099.

[49] Nogueira P, Bombarda—Rocha V, Tavares—Henriques R, Carneiro M, Sousa E, Gonçalves J, et al. Structure Meets Function: Dissecting Fucoxanthin’s Bioactive Architecture. Mar Drugs. 2025; 23: 440.

[50] Lee N, Youn K, Yoon JH, Lee B, Kim DH, Jun M. The Role of Fucoxanthin as a Potent Nrf2 Activator via Akt/GSK—3β/Fyn Axis against Amyloid—β Peptide—Induced Oxidative Damage. Antioxidants. 2023; 12: 629.

[51] Wang R, Paul VJ, Luesch H. Seaweed extracts and unsaturated fatty acid constituents from the green alga Ulva lactuca as activators of the cytoprotective Nrf2—ARE pathway. Free Radic Biol Med. 2013; 57: 141-53.

[52] Chini A, Monte I, Zamarreño AM, García—Mina JM, Solano R. Evolution of the jasmonate ligands and their biosynthetic pathways. New Phytol. 2023; 238: 2236-46.

[53] Goetz S, Hellwege A, Stenzel I, Kutter C, Hauptmann V, Forner S, et al. Role of cis—12—Oxo—Phytodienoic Acid in Tomato Embryo Development. Plant Physiol. 2012; 158: 1715-27.

[54] Adhikari A, Kaur S, Forouhar F, Kale S, Park SW. OPDA signaling channels resource (e−) allocation from the photosynthetic electron transfer chain to plastid cysteine biosynthesis in defense activation. J Exp Bot. 2024; 76: 594-606.

[55] Delker C, Stenzel I, Hause B, Miersch O, Feussner I, Wasternack C. Jasmonate Biosynthesis in Arabidopsis thaliana — Enzymes, Products, Regulation. Plant Biol. 2006; 8: 297-306.

[56] Hamberg M, Fahlstadius P. Allene oxide cyclase: a new enzyme in plant lipid metabolism. Arch Biochem Biophys. 1990; 276: 518—26.

[57] Howe GA, Major IT, Koo AJ. Modularity in Jasmonate Signaling for Multistress Resilience. Annu Rev Plant Biol. 2018; 69: 387-415.

[58] Ueda M, Kaji T, Kozaki W. Recent Advances in Plant Chemical Biology of Jasmonates. Int J Mol Sci. 2020; 21: 1124.

[59] Wasternack C, Strnad M. Jasmonates: News on Occurrence, Biosynthesis, Metabolism and Action of an Ancient Group of Signaling Compounds. Int J Mol Sci. 2018; 19: 2539.

[60] Wasternack C, Song S. Jasmonates: biosynthesis, metabolism, and signaling by proteins activating and repressing transciption. J Exp Bot. 2016; 68: 1303-21.

[61] Maynard D, Gröger H, Dierks T, Dietz KJ. The function of the oxylipin 12—oxophytodienoic acid in cell signaling, stress acclimation, and development. J Exp Bot. 2018; 69: 5341-54.

[62] Vick BA, Zimmerman DC. Pathways of Fatty Acid Hydroperoxide Metabolism in Spinach Leaf Chloroplasts. Plant Physiol. 1987; 85: 1073—8.

[63] Farmer EE, Ryan CA. Octadecanoid Precursors of Jasmonic Acid Activate the Synthesis of Wound—Inducible Proteinase Inhibitors. Plant Cell. 1992; 4: 129—34.

[64] Stintzi A, Weber H, Reymond P, Browse J, Farmer EE. Plant defense in the absence of jasmonic acid: The role of cyclopentenones. Proc Natl Acad Sci. 2001; 98: 12837—42.

[65] Dave A, Vaistij FE, Gilday AD, Penfield SD, Graham IA. Regulation of Arabidopsis thaliana seed dormancy and germination by 12—oxo—phytodienoic acid. J Exp Bot. 2016; 67: 2277-84.

[66] Park SW, Li W, Viehhauser A, He B, Kim S, Nilsson AK, et al. Cyclophilin 20—3 relays a 12—oxo—phytodienoic acid signal during stress responsive regulation of cellular redox homeostasis. Proc Natl Acad Sci. 2013; 110: 9559-64.

[67] Dixon DP, Edwards R. Selective Binding of Glutathione Conjugates of Fatty Acid Derivatives by Plant Glutathione Transferases. J Biol Chem. 2009; 284: 21249—56.

[68] Knieper M, Vogelsang L, Guntelmann T, Sproß J, Gröger H, Viehhauser A, et al. OPDAylation of Thiols of the Redox Regulatory Network In Vitro. Antioxidants. 2022; 11: 855.

[69] Ueda M, Saito R, Nishizato Y, Kitajima T, Kato N. Downstream metabolites of (+)—cis—12—oxo—phytodienoic acid function as noncanonical bioactive jasmonates in Arabidopsis thaliana. Nat Commun. 2025; 16: 6683.

[70] Ritter A, Goulitquer S, Salaün JP, Tonon T, Correa JA, Potin P. Copper stress induces biosynthesis of octadecanoid and eicosanoid oxygenated derivatives in the brown algal kelp Laminaria digitata. New Phytol. 2008; 180: 809-21.

[71] Barbosa M, Valentão P, Andrade PB. Biologically Active Oxylipins from Enzymatic and Nonenzymatic Routes in Macroalgae. Mar Drugs. 2016; 14: 23.

[72] Yamamoto Y, Ohshika J, Takahashi T, Ishizaki K, Kohchi T, Matusuura H, et al. Functional analysis of allene oxide cyclase, MpAOC, in the liverwort Marchantia polymorpha. Phytochemistry. 2015; 116: 48-56.

[73] Stumpe M, Göbel C, Faltin B, Beike AK, Hause B, Himmelsbach K, et al. The moss Physcomitrella patens contains cyclopentenones but no jasmonates: mutations in allene oxide cyclase lead to reduced fertility and altered sporophyte morphology. New Phytol. 2010; 188: 740-9.

[74] Ogorodnikova AV, Mukhitova FK, Grechkin AN. Oxylipins in the spikemoss Selaginella martensii: Detection of divinyl ethers, 12—oxophytodienoic acid and related cyclopentenones. Phytochemistry. 2015; 118: 42-50.

[75] Liu W, Park SW. 12—oxo—Phytodienoic Acid: A Fuse and/or Switch of Plant Growth and Defense Responses? Front Plant Sci. 2021; 12: 724079.

[76] Wasternack C, Feussner I. The Oxylipin Pathways: Biochemistry and Function. Annu Rev Plant Biol. 2018; 69: 363-86.

[77] Kneeshaw S, Soriano G, Monte I, Hamberg M, Zamarreño ÁM, García—Mina JM, et al. Ligand diversity contributes to the full activation of the jasmonate pathway in Marchantia polymorpha. Proc Natl Acad Sci. 2022; 119: e2202930119.

[78] Knieper M, Viehhauser A, Dietz KJ. Oxylipins and Reactive Carbonyls as Regulators of the Plant Redox and Reactive Oxygen Species Network under Stress. Antioxidants. 2023; 12: 814.

[79] Maynard D, Viehhauser A, Knieper M, Dreyer A, Manea G, Telman W, et al. The In Vitro Interaction of 12—Oxophytodienoic Acid and Related Conjugated Carbonyl Compounds with Thiol Antioxidants. Biomolecules. 2021; 11: 457.

[80] Savchenko T, Kolla VA, Wang CQ, Nasafi Z, Hicks DR, Phadungchob B, et al. Functional Convergence of Oxylipin and Abscisic Acid Pathways Controls Stomatal Closure in Response to Drought. Plant Physiol. 2014; 164: 1151—60.

[81] Adhikari A, Park SW. Reduced GSH Acts as a Metabolic Cue of OPDA Signaling in Coregulating Photosynthesis and Defense Activation under Stress. Plants. 2023; 12: 3745.

[82] Jackson PA, Widen JC, Harki DA, Brummond KM. Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β—Unsaturated Carbonyls with Thiols via Hetero—Michael Addition Reactions. J Med Chem. 2016; 60: 839-85.

[83] Yi R, Li Y, Shan X. OPDA/dn—OPDA actions: biosynthesis, metabolism, and signaling. Plant Cell Rep. 2024; 43: 206.

[84] Zhu M, Zhu N, Song WY, Harmon AC, Assmann SM, Chen S. Thiol—based redox proteins in abscisic acid and methyl jasmonate signaling in Brassica napus guard cells. Plant J. 2014; 78: 491-515.

[85] Zhang DP, Chen SW, Peng YB, Shen YY. Abscisic acid—specific binding sites in the flesh of developing apple fruit. J Exp Bot. 2001; 52: 2097-103.

[86] Wang K, Guo Q, Froehlich JE, Hersh HL, Zienkiewicz A, Howe GA, et al. Two Abscisic Acid—Responsive Plastid Lipase Genes Involved in Jasmonic Acid Biosynthesis in Arabidopsis thaliana. Plant Cell. 2018; 30: 1006-22.

[87] Simeoni F, Skirycz A, Simoni L, Castorina G, de Souza LP, Fernie AR, et al. The AtMYB60 transcription factor regulates stomatal opening by modulating oxylipin synthesis in guard cells. Sci Rep. 2022; 12: 533.

[88] Sun X, Hu C, Tan Q, Liu J, Liu H. Effects of molybdenum on expression of cold—responsive genes in abscisic acid (ABA)—dependent and ABA—independent pathways in winter wheat under low—temperature stress. Ann Bot. 2009; 104: 345-56.

[89] Izquierdo—Bueno I, González—Rodríguez VE, Simon A, Dalmais B, Pradier JM, Le Pêcheur P, et al. Bfs the key enzyme in Botrytis cinerea. Environ Microbiol. 2018; 20: 2469—82.

[90] Takino J, Kozaki T, Ozaki T, Liu C, Minami A, Oikawa H. Elucidation of biosynthetic pathway of a plant hormone abscisic acid in phytopathogenic fungi. Biosci Biotechnol Biochem. 2019; 83: 1642—9.

[91] Brill ZG, Condakes ML, Ting CP, Maimone TJ. Navigating the Chiral Pool in the Total Synthesis of Complex Terpene Natural Products. Chem Rev. 2017; 117: 11753—95.

[92] Friess M, Sahrawat AS, Kerschbaumer B, Wallner S, Torvisco A, Fischer R, et al. Asymmetric Synthesis of Chiral 2—Cyclohexenones with Quaternary Stereocenters via Ene—Reductase Catalyzed Desymmetrization of 2,5—Cyclohexadienones. ACS Catal. 2024; 14: 7256-66.

[93] Quintard A, Rodriguez J. Synergistic Cu—amine catalysis for the enantioselective synthesis of chiral cyclohexenones. Chem Commun. 2015; 51: 9523—6.

[94] Ghavre M, Froese J, Murphy B, Simionescu R, Hudlicky T. A Formal Approach to Xylosmin and Flacourtosides E and F: Chemoenzymatic Total Synthesis of the Hydroxylated Cyclohexenone Carboxylic Acid Moiety of Xylosmin. Org Lett. 2017; 19: 1156—9.

[95] Gharib A, Marquez C, Meseguer—Beltran M, Sanchez—Sarasua S, Sanchez—Perez AM. Abscisic acid, an evolutionary conserved hormone: Biosynthesis, therapeutic and diagnostic applications in mammals. Biochem Pharmacol. 2024; 229: 116521.

[96] Lievens L, Pollier J, Goossens A, Beyaert R, Staal J. Abscisic Acid as Pathogen Effector and Immune Regulator. Front Plant Sci. 2017; 8: 587.

[97] Yang X, Wang J, Li P. Recent progress on asymmetric organocatalytic construction of chiral cyclohexenone skeletons. Org Biomol Chem. 2014; 12: 2499-513.

[98] Jiang D, Wen L, Fan F. Synthesizing cyclohex—2—enone derivatives and exploring their bioactivities for drug discovery. Tetrahedron Lett. 2024; 135: 154877.

[99] Eronen A, Nieger M, Kajander TA, Repo T. Stereospecific Synthesis of Cyclohexenone Acids by [3,3]—Sigmatropic Rearrangement Route. J Org Chem. 2023; 88: 12914—23.

[100] El—Maslahi H, Turek I, Bi C, Wong A, Tzfadia O, Irving H, et al. Functions and Synthesis of Abscisic Acid (ABA) in Humans—Insights from Computational Approaches. Int J Mol Sci. 2025; 26: 11115.

[101] Groenewald EG, van der Westhuizen AJ. Prostaglandins and related substances in plants. Bot Rev. 1997; 63: 199-220.

[102] Traidl—Hoffmann C, Mariani V, Hochrein H, Karg K, Wagner H, Ring J, et al. Pollen—associated phytoprostanes inhibit dendritic cell interleukin—12 production and augment T helper type 2 cell polarization. J Exp Med. 2005; 201: 627—36.

[103] Di Costanzo F, Di Dato V, Ianora A, Romano G. Prostaglandins in Marine Organisms: A Review. Mar Drugs. 2019; 17: 428.

[104] Di Dato V, Barbarinaldi R, Amato A, Di Costanzo F, Fontanarosa C, Perna A, et al. Variation in prostaglandin metabolism during growth of the diatom Thalassiosira rotula. Sci Rep. 2020; 10: 5374.

[105] Altiok N, Mezzadra H, Patel P, Koyuturk M, Altiok S. A plant oxylipin, 12—oxo—phytodienoic acid, inhibits proliferation of human breast cancer cells by targeting cyclin D1. Breast Cancer Res Treat. 2007; 109: 315-23.

[106] Taki—Nakano N, Ohzeki H, Kotera J, Ohta H. Cytoprotective effects of 12—oxo phytodienoic acid, a plant—derived oxylipin jasmonate, on oxidative stress—induced toxicity in human neuroblastoma SH—SY5Y cells. Biochim Biophys Acta (BBA) — Gen Subj. 2014; 1840: 3413—22.

[107] Rotem R, Fingrut O, Moskovitz J, Flescher E. The anticancer agent methyl jasmonate induces activation of stress—regulated c—Jun N—terminal kinase and p38 protein kinase in human lymphoid cells. Leukemia. 2003; 17: 2230—4.

[108] Tanel A, Averill—Bates DA. Inhibition of Acrolein—Induced Apoptosis by the Antioxidant N—Acetylcysteine. J Pharmacol Exp Ther. 2007; 321: 73-83.

[109] Bömer M, Pérez—Salamó I, Florance HV, Salmon D, Dudenhoffer JH, Finch P, et al. Jasmonates induce Arabidopsis bioactivities selectively inhibiting the growth of breast cancer cells through CDC6 and mTOR. New Phytol. 2020; 229: 2120—34.

[110] Jarocka—Karpowicz I, Markowska A. Jasmonate Compounds and Their Derivatives in the Regulation of the Neoplastic Processes. Molecules. 2021; 26: 2901.

[111] Sharma G, Badruddeen, Akhtar J, Khan MI, Ahmad M, Sharma PK. “Methyl jasmonate: bridging plant defense mechanisms and human therapeutics”. Naunyn—Schmiedeb Arch Pharmacol. 2025; 398: 6429—51.

[112] Knieper M, Schwarz R, Vogelsang L, Sproß J, Kaya A, Bittmann M, et al. The competitive interplay of 12—oxophytodienoic acid (OPDA), protein thiols, and glutathione. FEBS J. 2026; 293: 3683-705.

[113] Póti ÁL, Bálint D, Alexa A, Sok P, Ozsváth K, Albert K, et al. Targeting a key protein—protein interaction surface on mitogen—activated protein kinases by a precision—guided warhead scaffold. Nat Commun. 2024; 15: 8607.

[114] Hujjat SFZ, Chandani HK, Khan MS, Chandani DK, Mahmoud A. Bruton’s tyrosine kinase inhibition in ITP: Wayrilz (rilzabrutinib) as a disease—modifying strategy. Ann Med Surg. 2025; 87: 7907—9.

[115] Bálint D, Póti ÁL, Alexa A, Sok P, Albert K, Torda L, et al. Reversible covalent c—Jun N—terminal kinase inhibitors targeting a specific cysteine by precision—guided Michael—acceptor warheads. Nat Commun. 2024; 15: 8606.

[116] Salomatina OV, Markov AV, Logashenko EB, Korchagina DV, Zenkova MA, Salakhutdinov NF, et al. Synthesis of novel 2—cyano substituted glycyrrhetinic acid derivatives as inhibitors of cancer cells growth and NO production in LPS—activated J—774 cells. Bioorg Med Chem. 2014; 22: 585-93.

[117] Dayalan Naidu S, Dinkova—Kostova AT. Omaveloxolone (SkyclarysTM) for patients with Friedreich’s ataxia. Trends Pharmacol Sci. 2023; 44: 394-5.

[118] Dayalan Naidu S, Muramatsu A, Saito R, Asami S, Honda T, Hosoya T, et al. C151 in KEAP1 is the main cysteine sensor for the cyanoenone class of NRF2 activators, irrespective of molecular size or shape. Sci Rep. 2018; 8: 8037.

[119] Yang S, Liao Y, Li L, Xu X, Cao L. Zeylenone Induces Mitochondrial Apoptosis and Inhibits Migration and Invasion in Gastric Cancer. Molecules. 2018; 23: 2149.

[120] Zhang L, Huo X, Liao Y, Yang F, Gao L, Cao L. Zeylenone, a naturally occurring cyclohexene oxide, inhibits proliferation and induces apoptosis in cervical carcinoma cells via PI3K/AKT/mTOR and MAPK/ERK pathways. Sci Rep. 2017; 7: 1669.

[121] Zhang P, de Gooijer MC, Buil LC, Beijnen JH, Li G, van Tellingen O. ABCB1 and ABCG2 restrict the brain penetration of a panel of novel EZH2—Inhibitors. Int J Cancer. 2015; 137: 2007-18.

[122] Su R, Cao W, Ma G, Li W, Li Z, Liu Y, et al. Cyclohexene oxide CA, a derivative of zeylenone, exhibits anti—cancer activity in glioblastoma by inducing G0/G1 phase arrest through interference with EZH2. Front Pharmacol. 2024; 14: 1326245.

[123] Hsiang CH, Straus DS. Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF—7 breast cancer cells. Oncogene. 2002; 21: 2212-26.

[124] Conti M. Cyclopentenone: a special moiety for anticancer drug design. Anti—Cancer Drugs. 2006; 17: 1017—22.

[125] Vetvicka V, Vannucci L. Biological properties of andrographolide, an active ingredient of Andrographis Paniculata: a narrative review. Ann Transl Med. 2021; 9: 1186.

[126] Li X, Yuan W, Wu J, Zhen J, Sun Q, Yu M. Andrographolide, a natural anti—inflammatory agent: An Update. Front Pharmacol. 2022; 13: 920435.

[127] Messire G, Rollin P, Gillaizeau I, Berteina—Raboin S. Synthetic Modifications of Andrographolide Targeting New Potential Anticancer Drug Candidates: A Comprehensive Overview. Molecules. 2024; 29: 2884.

[128] Ciucci A, Gianferretti P, Piva R, Guyot T, Snape TJ, Roberts SM, et al. Induction of Apoptosis in Estrogen Receptor—Negative Breast Cancer Cells by Natural and Synthetic Cyclopentenones: Role of the IκB Kinase/Nuclear Factor—κB Pathway. Mol Pharmacol. 2006; 70: 1812-21.

[129] Simeonov SP, Nunes JP, Guerra K, Kurteva VB, Afonso CA. Synthesis of Chiral Cyclopentenones. Chem Rev. 2016; 116: 5744-893.

[130] Usami Y, Asada N, Shizuma C, Negoro K, Kawai R, Kaneda S, et al. Synthesis of 5—Hydroxy—5—vinyl—2—cyclopentenones, a Family of Rare—Type Natural Products Mostly Recovered from Marine Sources. Mar Drugs. 2025; 23: 449.

[131] Reddy DM, Qazi NA, Sawant SD, Bandey AH, Srinivas J, Shankar M, et al. Design and synthesis of spiro derivatives of parthenin as novel anti—cancer agents. Eur J Med Chem. 2011; 46: 3210—7.

[132] Andrade KHS, Coelho JAS, Frade R, Madureira AM, Nunes JPM, Caddick S, et al. Front Cover: Functionalized Cyclopentenones with Low Electrophilic Character as Anticancer Agents (ChemMedChem 13/2023). ChemMedChem. 2023; 18: e18.

[133] Metz JT, Huth JR, Hajduk PJ. Enhancement of chemical rules for predicting compound reactivity towards protein thiol groups. J Comput—Aided Mol Des. 2007; 21: 139-44.

[134] Huth JR, Song D, Mendoza RR, Black—Schaefer CL, Mack JC, Dorwin SA, et al. Toxicological Evaluation of Thiol—Reactive Compounds Identified Using a La Assay To Detect Reactive Molecules by Nuclear Magnetic Resonance. Chem Res Toxicol. 2007; 20: 1752-9.

[135] Baell JB, Holloway GA. New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays. J Med Chem. 2010; 53: 2719-40.

[136] Chadwick M, Trewin H, Gawthrop F, Wagstaff C. Sesquiterpenoids Lactones: Benefits to Plants and People. Int J Mol Sci. 2013; 14: 12780—805.

[137] Amen Y, Abdelwahab G, Heraiz AA, Sallam M, Othman A. Exploring sesquiterpene lactones: structural diversity and antiviral therapeutic insights. RSC Adv. 2025; 15: 1970-88.

[138] Lagoutte R, Winssinger N. Following the Lead from Nature with Covalent Inhibitors. CHIMIA. 2017; 71: 703—11.

[139] Kaur N, Kaur L, Kaur M, Sohal HS, Sharma A, Attar GS, et al. A review on structural modifications of parthenin extracted from Parthenium hysterophorus L. Tetrahedron. 2025; 187: 134919.

[140] Mortenson DE, Brighty GJ, Plate L, Bare G, Chen W, Li S, et al. “Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates. J Am Chem Soc. 2017; 140: 200-10.

[141] Staneva JD, Todorova MN, Evstatieva LN. Sesquiterpene lactones as chemotaxonomic markers in genus Anthemis. Phytochemistry. 2008; 69: 607—18.

[142] Collu F, Bonsignore L, Casu M, Floris C, Gertsch J, Cottiglia F. New cytotoxic saturated and unsaturated cyclohexanones from Anthemis maritima. Bioorg Med Chem Lett. 2008; 18: 1559-62.

[143] Hamilton DS, Zhang X, Ding Z, Hubatsch I, Mannervik B, Houk KN, et al. Mechanism of the Glutathione Transferase—Catalyzed Conversion of Antitumor 2—Crotonyloxymethyl—2—cycloalkenones to GSH Adducts. J Am Chem Soc. 2003; 125: 15049—58.

[144] Zhang Q, Ding Z, Creighton DJ, Ganem B, Fabris D. Alkylation of Nucleic Acids by the Antitumor Agent COMC. Org Lett. 2002; 4: 1459-62.

[145] Joseph E, Ganem B, Eiseman JL, Creighton DJ. Selective Inhibition of MCF—7^piGST Breast Tumors Using Glutathione Transferase—Derived 2—Methylene—cycloalkenones. J Med Chem. 2005; 48: 6549—52.

[146] Arthurs CL, Morris GA, Piacenti M, Pritchard RG, Stratford IJ, Tatic T, et al. The synthesis of 2—oxyalkyl—cyclohex—2—enones, related to the bioactive natural products COTC and antheminone A, which possess anti—tumour properties. Tetrahedron. 2010; 66: 9049-60.

[147] Liu J, Liu X, Qian J, Meng C, Zhu P, Hang J, et al. Development of pH/Glutathione—Responsive Theranostic Agents Activated by Glutathione S—Transferase π for Human Colon Cancer. J Med Chem. 2020; 63: 9271—83.

[148] Fox BM, Vroman JA, Fanwick PE, Cushman M. Preparation and Evaluation of Sulfide Derivatives of the Antibiotic Brefeldin A as Potential Prodrug Candidates with Enhanced Aqueous Solubilities. J Med Chem. 2001; 44: 3915-24.

[149] Zhang Q, Lu Y, Ding Y, Zhai J, Ji Q, Ma W, et al. Guaianolide Sesquiterpene Lactones, a Source To Discover Agents That Selectively Inhibit Acute Myelogenous Leukemia Stem and Progenitor Cells. J Med Chem. 2012; 55: 8757-69.

[150] Bousquet MS, Ratnayake R, Pope JL, Chen QY, Zhu F, Chen S, et al. Seaweed natural products modify the host inflammatory response via Nrf2 signaling and alter colon microbiota composition and gene expression. Free Radic Biol Med. 2020; 146: 306-23.

[151] Lu S, Ren L, Mao D, Kakeya H. Mechanistic study of the retro—aza—Michael reaction in saccharothriolide L: identification of 2—amino—4—methylphenol as an effective protecting tool for the Michael acceptor. J Antibiot (Tokyo). 2024; 77: 544-7.

[152] Takenaka K, Kaneko K, Takahashi N, Nishimura S, Kakeya H. Retro—aza—Michael reaction of an o—aminophenol adduct in protic solvents inspired by natural products. Bioorg Med Chem. 2021; 35: 116059.

[153] Lu S, Nishimura S, Ito M, Tsuchida T, Kakeya H. Isolation and Structure Elucidation of Cytotoxic Saccharothriolides D to F from a Rare Actinomycete Saccharothrix sp. and Their Structure—Activity Relationship. J Nat Prod. 2016; 79: 1891—5.

[154] Mullard A. FDA approves 100th small—molecule kinase inhibitor. Nat Rev Drug Discov. 2025; 24: 891—5.